Clinical trial
Subconjunctival Aflibercept Injection for Corneal Neovascularization
NCT01868360 is registered in ClinicalTrials.gov with Balamurali Ambati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Subconjunctival Aflibercept Injection for Corneal Neovascularization
- Lead sponsor
- Balamurali Ambati
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- June 30, 2013
- Completion date
- October 31, 2015
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.